COSA 2015* , ,
Presentations this author is a contributor to:
A cost-benefit evaluation of prophylactic biosimilar filgrastim for breast cancer patients receiving adjuvant TC chemotherapy. (#305)
3:00 PM
Lisa Crisp
Posters 2